Epigral Limited (NSE:EPIGRAL)

Epigral Revenue

In the fiscal year ending March 31, 2026, Epigral had annual revenue of 25.27B INR, down -0.90%. Epigral had revenue of 7.36B in the quarter ending March 31, 2026, with 17.29% growth.

• Revenue: 25.27B
• Revenue Growth: -0.90%
• P/S Ratio: 1.93
• Revenue / Employee: 23.57M
• Employees: 1,072
• Market Cap: 48.76B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	25.27B	-229.50M	-0.90%
Mar 31, 2025	25.50B	6.21B	32.19%
Mar 31, 2024	19.29B	-2.59B	-11.84%
Mar 31, 2023	21.88B	6.37B	41.10%
Mar 31, 2022	15.51B	7.22B	87.18%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error